Why should you attend?

The premier event for top executives on Aspetic Processing | Gene & Cell Therapies

Key Learning Points

GCT Track

  • Navigating Regulatory Requirements: Key Considerations in Bringing Gene Therapies to Market
  • Optimizing Vector Serotypes for Durable Gene Expression
  • Strategic Vector Design and Development for Effective Gene and Cell Therapies
  • Investor Perspectives on Gene Therapy Development: Insights and Strategies
  • Reducing Timelines in Cell and Gene Therapy Drug Development: Success Stories and Challenges
  • CMC Strategies Tailored for Rare Diseases in Gene and Cell Therapies
  • Novel Approaches to Qualifying Starting and Intermediary Materials in CGT Processing
  • Strategies for Accelerating CGT Process Development from Preclinical to Commercialization
  • Controlling Immunogenicity: Developing Novel Vectors for Safer Gene Therapies
  • Pediatric Gene Therapy: Nuclease-Free Genomic Editing and Development Challenges

APT Track

  • The Evolution of Aseptic Technologies
  • Cleanrooms for Annex 1 Updates: Implementation Challenges and Best Practices
  • Innovative Approaches in Quality Risk Management for Aseptic Processes
  • Navigating Antibody Drug Conjugates (ADCs) and Highly Potent APIs (HPAPIs) Production
  • Advancements in Lyophilization for Highly Potent Products and Aseptic Processing
  • Occupational Safety Requirements in Aseptic Environments
  • Overcoming Technical Challenges in Decontamination Processes for Enhanced Safety
  • Robotic Applications in Aseptic Processing: Current Status and Future Trends
  • Single-Use Systems Implementation in Aseptic Environments
  • Enhancing Filtration: Strategies for Effective Filter Integrity Testing in Aseptic Operations

Who should attend?

Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments from pharmaceutical/biotechnology industry / industries involved in:

  • Adenovirus
  • Advanced Therapy Medicinal Product
  • Analytics
  • Bioprocess Research
  • Bioprocessing
  • Biotechnology
  • Biotherapeutics
  • Cell Engineering
  • Cell Therapy
  • Cell-Based Medicinal Products
  • Cellular Immunotherapy
  • Cellular Therapy
  • CMC
  • CAR-T
  • Clinical Development
  • Commercialisation
  • Comparability
  • Compliance
  • Container Development
  • Drug Development
  • Engineering
  • Fill and Finish
  • Formulation
  • Freeze-Drying
  • Gene Therapy
  • GMP
  • Immuno-Oncology
  • Immunology
  • Immunotherapy
  • Lentivirus
  • Licensing
  • Lyophilisation
  • Manufacturing
  • Market Access
  • Medical Affairs
  • Medical Devices
  • Nanomaterials
  • Non-Viral Vectors
  • Oncology
  • Packaging and Labelling
  • Parenterals
  • Pharmaceutical Process and Technology
  • Process Analytics
  • Process Development
  • Process Monitoring and Control
  • Product Characterisation
  • Product Innovation
  • Production Engineering
  • QA/QC
  • Quality Assurance
  • Quality Control
  • R&D
  • Regenerative Medicine
  • Regulatory Affairs
  • Research and Development
  • Risk Management
  • Safety
  • Scale Up
  • Stability
  • Standardisation Science
  • Stem Cell
  • Sterilization
  • Supply Chain
  • Vaccine/Antibody/Cell Manufacturing
  • Validation
  • Viral Vector

What can you expect?


➜ 100+ industry delegates

➜ 60%+ C-suite executives & SP-VP

➜ 10+ Exhibitors & Sponsors

➜ Experts on APT | GCT | CMC | Bioprocessing and many more…

➜ 5+ hours of networking events

➜ Exclusive innovative data

➜ Delegates contact information

Companies Represented on our events

Our Clients


Several major clients have trusted on us making BPS one of the best conferences for executives in the World.

Early bird Registration is now open!

Register now before price goes up!